Family Office Of America (FOFA) Common Equity (2021 - 2026)
Family Office Of America's (FOFA) quarterly Common Equity came in at $966111.0 in Q1 2026, up 85.5% year-on-year from $520814.0 in Q1 2025, and up 45.39% quarter-over-quarter from $664509.0 in Q4 2025.
Family Office Of America (FOFA) Common Equity (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed Common Equity across 6 years of filings, most recently posting $966111.0 for Q1 2026.
- Common Equity for Q1 2026 came in at $966111.0, up 85.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $966111.0 (up 85.5% YoY), and the FY2025 annual result was $664509.0, up 2934.94% from the prior year.
- Common Equity came in at $966111.0 for Q1 2026 at Family Office Of America, up from $664509.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $966111.0 in Q1 2026 to a low of -$522956.0 in Q4 2023.
- The 5-year median for Common Equity is $223954.0 (2022), against an average of $295497.2.
- Across the five-year window, Common Equity tumbled 333.51% in 2023 and jumped 11413.83% in 2025, its largest moves.
- Family Office Of America's Common Equity stood at $223954.0 in 2022, then slumped by 333.51% to -$522956.0 in 2023, then jumped by 95.52% to -$23440.0 in 2024, then soared by 2934.94% to $664509.0 in 2025, then soared by 45.39% to $966111.0 in 2026.
- The last three Common Equity figures came in at $966111.0 (Q1 2026), $664509.0 (Q4 2025), and $803665.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Family Office Of America | - | - | 783,126.00 | 966,111.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 966,111.00 |
| Dec 31, 2025 | 664,509.00 |
| Sep 30, 2025 | 803,665.00 |
| Jun 30, 2025 | 554,396.00 |
| Mar 31, 2025 | 520,814.00 |
| Dec 31, 2024 | -23,440.00 |
| Sep 30, 2024 | 6,980.00 |
| Jun 30, 2024 | 29,656.00 |
| Mar 31, 2024 | 60,884.00 |
| Dec 31, 2023 | -522,956.00 |
| Sep 30, 2023 | 98,449.00 |
| Jun 30, 2023 | 127,021.00 |
| Mar 31, 2023 | 161,674.00 |
| Dec 31, 2022 | 223,954.00 |
| Sep 30, 2022 | 371,156.00 |
| Jun 30, 2022 | 381,999.00 |
| Mar 31, 2022 | 598,580.00 |
| Dec 31, 2021 | 770,415.00 |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 1.53 Mn |